Literature DB >> 1645778

Mutational analysis of the equine infectious anemia virus Tat-responsive element.

M Carvalho1, D Derse.   

Abstract

A hairpinlike structure is predicted to exist at the 5' end of equine infectious anemia virus (EIAV) RNA which is similar in many ways to the human immunodeficiency type 1 (HIV-1) Tat-responsive element (TAR). In EIAV, this structure has a shorter stem than in HIV-1 and lacks the uridine bulge. Primer extension analysis of EIAV RNA was used to identify the transcriptional start site in the viral long terminal repeat. Premature termination of primer elongation at the predicted double-stranded RNA region was frequently observed and suggests that the inferred hairpin structure exists under these conditions. We have functionally characterized EIAV TAR by site-directed mutagenesis and transient gene expression analysis. It is demonstrated here that the secondary structure of this element is essential for Tat action. Mutations that disrupted base pairing abolished TAR function, and compensatory mutations that restored the stem structure resulted in Tat activation. The TAR loop appears to be closed by two U.G base pairs that are likely to provide a unique structural motif recognized by the Tat protein. With one exception, substitutions of nucleotides within the EIAV loop sequence decreased TAR function. All nucleotide substitutions of the cytidine at position +14 increased EIAV Tat responsiveness; however, its deletion abolished trans activation. Our results lead us to propose that the EIAV and HIV-1 Tat systems employ closely related cis- and trans-acting components that probably act by the same mechanism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645778      PMCID: PMC241331     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Functions of the auxiliary gene products of the human immunodeficiency virus type 1.

Authors:  B R Cullen; W C Greene
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

2.  Fragments of the HIV-1 Tat protein specifically bind TAR RNA.

Authors:  K M Weeks; C Ampe; S C Schultz; T A Steitz; D M Crothers
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

3.  Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization.

Authors:  H Siomi; H Shida; M Maki; M Hatanaka
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

4.  Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.

Authors:  M J Selby; B M Peterlin
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

5.  Solution conformation of an RNA hairpin loop.

Authors:  J D Puglisi; J R Wyatt; I Tinoco
Journal:  Biochemistry       Date:  1990-05-01       Impact factor: 3.162

6.  HIV-1 tat trans-activation requires the loop sequence within tar.

Authors:  S Feng; E C Holland
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

Authors:  P Dorn; L DaSilva; L Martarano; D Derse
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

8.  Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.

Authors:  R M Stephens; D Derse; N R Rice
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

9.  Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.

Authors:  B R Cullen
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

10.  Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

Authors:  J A Garcia; D Harrich; E Soultanakis; F Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  29 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.

Authors:  Robert Hines; Brenda R Sorensen; Madeline A Shea; Wendy Maury
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments.

Authors:  Tim van Opijnen; Maarten C Boerlijst; Ben Berkhout
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras.

Authors:  R Carroll; L Martarano; D Derse
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Genetic variation in the long terminal repeat associated with the transition of Chinese equine infectious anemia virus from virulence to avirulence.

Authors:  Lili Wei; Xiujuan Fan; Xiaoling Lu; Liping Zhao; Wenhua Xiang; Xiaoyan Zhang; Fei Xue; Yiming Shao; Rongxian Shen; Xiaojun Wang
Journal:  Virus Genes       Date:  2009-01-07       Impact factor: 2.332

6.  High-Efficiency Rescue of Equine Infectious Anemia Virus from a CMV-Driven Infectious Clone.

Authors:  Xue-Feng Wang; Bowen Bai; Yuezhi Lin; Ting Qi; Cheng Du; Mingxin Song; Xiaojun Wang
Journal:  Virol Sin       Date:  2019-08-02       Impact factor: 4.327

7.  Functional differences between human and bovine immunodeficiency virus Tat transcription factors.

Authors:  H P Bogerd; H L Wiegand; P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

8.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

9.  Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.

Authors:  Udayan Chatterji; Aymeric de Parseval; John H Elder
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.

Authors:  W Tan; M Schalling; C Zhao; M Luukkonen; M Nilsson; E M Fenyö; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.